Consumer Health Cancer / Oncology

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

Zhongxin launched the Program aiming to navigate and solve the medication challenges faced by cancer patients. During cancer treatment process, the use of ...

 January 20, 2023 | News

South Korean diagnostics company NGeneBio is accelerating its expansion into the ASEAN precision diagnosis market.

▶ Securing breast and ovarian cancer precision diagnosis reference through clinical evaluation ▶ Expansion of opportunities to develops global advance...

 January 19, 2023 | News

Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes

Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...

 January 19, 2023 | News

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...

 January 11, 2023 | News

Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong

Luye Pharma has signed an agreement with Abacus Medicine Pharma Services (AMPS), an international healthcare and pharmaceutical services company, the terms...

 January 10, 2023 | News

Agilent Announces Expansion of Portfolio With Acquisition of Avida Biomed

Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent T...

 January 06, 2023 | News

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...

 January 05, 2023 | News

The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them

For a field like cancer research, in which progress can sometimes appear to happen slowly, it is especially important to remind ourselves of the crucial ad...

 December 31, 2022 | News | By Calley Jones, PhD

Non-invasive in vitro diagnostic (IVD) test enables early detection of colorectal cancer

Stool sample collection kit, DNA Isolation Kit and Sample Pretreatment Kit for Methylation Detection, which are used in conjunction with this detection pro...

 December 28, 2022 | News

Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...

 December 23, 2022 | News

Prenetics Acquires ACT Genomics

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genom...

 December 16, 2022 | News

Janssen Submits Biologics License Application to U.S. FDA

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Biologics License Application (BLA) to the U.S. Food and ...

 December 12, 2022 | News

Exact Sciences to Advance Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for it...

 December 12, 2022 | News

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

Presently, most cancer diagnosis is done through thinly sliced physical biopsies. Though widespread, the amount of information this method collects remains...

 December 06, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in